Qube Research & Technologies Ltd
Position in SRPT — Sarepta Therapeutics, Inc.
CIK 1729829
LONDON, X0
Position in SRPT
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$10,958,034
-$16,375,837 QoQ
Shares Held
609,796
-61.9% QoQ
Ownership
0.577%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#34
of 323 holders
Holding Since
Jun 2020
10 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in SRPT Over Time
Shares Held
Position Value (USD)
Derivatives in SRPT
reported options exposure · as of Jun 30, 2025CallValue
$30,780
CallShares
1,800
PutValue
$1,710
PutShares
100
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Biotechnology
Healthcare · as of Jun 30, 2026Qube Research & Technologies Ltd holds $2,437,858,262 across 168 Biotechnology names. SRPT ranks #42 (0.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
798,715 | $240,437,176 | |
| 2 | INSM |
INSMED Inc
|
1,682,334 | $179,370,451 | |
| 3 | REGN |
Regeneron Pharmaceuticals, Inc.
|
221,607 | $138,180,828 | |
| 4 | ROIV |
Roivant Sciences Ltd.
|
3,454,496 | $122,254,613 | |
| 5 | AXSM |
Axsome Therapeutics, Inc.
|
426,336 | $104,354,262 | |
| 6 | APGE |
Apogee Therapeutics, Inc.
|
659,678 | $87,559,060 | |
| 7 | TVTX |
Travere Therapeutics, Inc.
|
1,443,230 | $81,989,896 | |
| 8 | RPRX |
Royalty Pharma plc
|
1,412,112 | $79,177,119 |
All Filings in SRPT
Export CSV
14 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $10,958,034 | 609,796 | Shares | Sole | 2026-08-14 | |
| 2025-06-30 | $1,710 | 100 | Put | Sole | 2025-08-14 | |
| 2025-06-30 | $30,780 | 1,800 | Call | Sole | 2025-08-14 | |
| 2025-06-30 | $27,333,871 | 1,598,472 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $63,820 | 1,000 | Call | Sole | 2025-05-15 | |
| 2025-03-31 | $6,382 | 100 | Put | Sole | 2025-05-15 | |
| 2025-03-31 | $2,036,368 | 31,908 | Shares | Sole | 2025-05-15 | |
| 2024-03-31 | $1,536,560 | 11,869 | Shares | Sole | 2024-05-14 | |
| 2023-12-31 | $117,548 | 1,219 | Shares | Sole | 2024-02-13 | |
| 2023-09-30 | $33,093 | 273 | Shares | Sole | 2023-11-13 | |
| 2022-09-30 | $1,406,953 | 12,728 | Shares | Sole | 2022-11-14 | |
| 2021-03-31 | $2,359,768 | 31,662 | Shares | Sole | 2021-05-14 | |
| 2020-12-31 | $6,090,755 | 35,725 | Shares | Sole | 2021-02-16 | |
| 2020-06-30 | $3,836,294 | 23,926 | Shares | Sole | 2020-08-14 | |
| No filing history on record for this holder in this stock. | ||||||